New drugs in the treatment of colorectal carcinoma
- 15 August 1998
- Vol. 83 (4) , 679-689
- https://doi.org/10.1002/(sici)1097-0142(19980815)83:4<679::aid-cncr8>3.0.co;2-f
Abstract
No abstract availableKeywords
This publication has 56 references indexed in Scilit:
- 1027: Distinct patterns of chromosomal imbalances in adenocarcinoma and squamous cell carcinoma of the lungEuropean Journal Of Cancer, 1997
- Pharmacokinetics and oral bioavailability of 9-amino-camptothecin PEG1000 capsulesEuropean Journal Of Cancer, 1997
- Uracil and tegafur modulated with leucovorinCancer, 1997
- Oxaliplatin with high-dose leucovorin and 5-fluorouracil 48-hour continuous infusion in pretreated metastatic colorectal cancerEuropean Journal Of Cancer, 1997
- Characterisation and Clinical Management of CPT-11 (Irinotecan)-induced Adverse Events: The European PerspectiveEuropean Journal Of Cancer, 1996
- Efficacy of oral tegafur modulation by uracil and leucovorin in advanced colorectal cancer. A phase II studyEuropean Journal Of Cancer, 1995
- ZD1694 (Tomudex): A new thymidylate synthase inhibitor with activity in colorectal cancerEuropean Journal Of Cancer, 1995
- A randomized trial of two schedules of trimetrexate versus 5-fluorouracil in advanced colorectal cancerAnti-Cancer Drugs, 1995
- Oxaliplatin activity against metastatic colorectal cancer. A phase II study of 5-day continuous venous infusion at circadian rhythm modulated rateEuropean Journal Of Cancer, 1993
- A chronopharmacologic phase II clinical trial with 5-fluorouracil, folinic acid, and oxaliplatin using an ambulatory multichannel programmable pump. High antitumor effectiveness against metastatic colorectal cancerCancer, 1992